Medicament for treating depression
CA 1330535 C · Owner: Glaxo Group Limited · Inventors: North, Peter Charles; Oxford, Alexander William; Coates, Ian Harold
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
MEDICAMENTS, The invention relates to the use of compounds of formula (I), (I), wherein Im represents an imidazolyl group of formula: or , and R1 represents a hydrogen atom or a group selected from C1-6alkyl, C3-6alkenyl, C3-10alkynyl C3-7cycloalkyl,C3-7cycloalkylC1-4alkyl phenyl, phenylC1-3alkyl, phenylmethoxymethyl phenoxyethyl, phenoxymethyl, -CO2R5, -COR5 -CONR5R6 or -SO2R5 (wherein, R5 and R6 which may be the same or different, each represents a hydrogen atom, a C1-6alkyl or C3-7cycloalkyl group, or a phenyl or phenylC1-4alkyl group in which the, phenyl group is optionally substituted by one or more C1-4alkyl, C1-4alkoxy or hydroxy groups or halogen atoms with the proviso that R5 does …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Granted July 5, 1994. A Canadian patent filed before October 1, 1989 lasted 17 years from grant, so its term ended July 5, 2011.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.